ADAPTOL ® [Mebicar]

Customer Reviews

Based on 3 reviews Write a review

Dosage and administration

The normal daily dose is 900 - 1800 mg: 300 - 600 mg thrice daily. The duration of a course of treatment can vary from several days to 2 months. If taken to relieve nicotine withdrawal symptoms, use 300 - 900 mg thrice daily for a period of 5 - 6 weeks.

Side effects

Side effects include allergic reactions (itchy skin), headaches, hypotension (low blood pressure), and low body temperature.

Overdose

An increase in potential side effects.

Note: Anecdotal reports in Russia show that Mebicar provides a good rapid effect in the majority of cases without causing sleepiness and grogginess. However, in 8 - 12 % of all cases, the drug appears either to be ineffective or to cause side effects.

Country of Manufacture: Russia

Availability: in stock

The product is available in different sizes and from different manufactures.

Mebicar was synthesized at the Institute of Organic Chemistry by Ukranian professor V. M. Povstian. In 1978, the USSR Ministry of Healthcare approved Mebicar for use by the general public as an anxiolytic and as a “daily” tranquilizer. Mebicar belongs to a group of non-benzodizepam tranquilizers; from the chemical perspective, it is a derivative of carbamide, an endogenous metabolite, which explains why the compound is 150 times less toxic than Diazepam.

Mebicar works on the serotonergic system: taken in small doses it increases the effect of triptofan, which is a precursor to serotonin.

Mebicar can be used by those who have the following symptoms:

  • Asthenic disorders
  • Depressions with anxiety
  • Various conditions characterised by reduced mental productivity
  • Extreme work conditions, e.g. excessive mental or physical exertion
  • Nicotine withdrawal
  • Impaired memory formation

Country of Manufacture: Russia / Latvia


Type: Nootropics




CUSTOMERS WHO BOUGHT THIS PRODUCT ALSO BOUGHT